Research led by Keshari Lab, a biochemist and bioengineer at MSK, found that immune cells might be reprogrammed to use the body’s fructose — a naturally occurring sugar — as an energy source that supercharges them to fight cancer. Learn more about this research and its potential

Keshari Lab Memorial Sloan Kettering Cancer Center GSK Graduate School engineered CD8+ T cells & CAR T cells to express the fructose-specific transporter GLUT5, to improve T cell glycolytic flux & thus effector function in glucose-limited conditions. 📖 the #researchhighlight 👇 bit.ly/3DPG2VT

Onward to more science! 🧬